ReviewFood chemistry. Molecular sciences2026
Targeting sweet taste receptor T1R2/T1R3: a new strategy for metabolic disease regulation and intervention of multiple organ diseases.
Review in Food chemistry. Molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The overconsumption of dietary sugars poses significant health risks, creating a conflict with the innate human preference for sweet taste. Beyond its role in taste perception on the tongue, the sweet taste receptor (STR, a heterodimer of T1R2/T1R3) serves as a crucial nutrient sensor in metabolic organs, including the gut and pancreas. Dysfunction of this receptor is linked to impaired metabolic regulation. This review comprehensively summarizes the structure and signaling pathways of T1R2/T1R3, with a particular focus on its interaction with various food-source sweet ligands, including natural sugars and sweeteners. We further discuss its implications in metabolic diseases and its role beyond taste in systems such as the immune system. Finally, we highlight the receptor's significant potential in food innovation, encompassing the development of novel sweeteners, tailored dietary strategies, and biosensors for food quality and safety, offering new avenues for managing health through diet.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.